Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-06-04
Item 5.02
The filing discloses the appointment of Jennifer Cabalquinto as a new independent Class I director to Playboy's Board on June 3, 2026. The appointment is material because it restored the Company's compliance with Nasdaq Listing Rule 5605(b)(1) requiring a majority independent board, and the disclosure provides extensive biographical detail and governance qualifications, indicating significance to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-04
Item 8.01
The disclosure announces the appointment of Annamaria Vitelli as Executive Vice President and Chief Wealth Officer of Provident Bank, with designation as an Executive Officer and Regulation O Officer. This is a clear executive appointment of a named individual to a senior officer role, which is material to investors assessing the registrant's management and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-04
Item 5.02
The Board appointed Johnathan Daniel to serve as interim Chief Accounting Officer effective mid-to-late June 2026, during Corbyn Lichon's maternity leave. Daniel's appointment includes a base salary of $300,000 and bonus structure, and is material to investors as it affects accounting and financial reporting oversight during the transition period.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-04
Item 5.02
The disclosure centers on the appointment of Michael E. Williamson as a Class III Director effective June 1, 2026, with the Board increasing from seven to eight directors. This is a clear director appointment under Item 5.02, and the Board's determination that Mr. Williamson is independent under SEC and Nasdaq standards makes this material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-04
Item 5.02
Direct Digital Holdings, Inc. appointed Ohad Harlev as an Independent Director to its Board, effective June 3, 2026. The Board increased its size in connection with this appointment, and Mr. Harlev will receive compensation under the company's director compensation program.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-03
Item 5.02
G. Michael Sievert was appointed to Alaska Air Group's Board of Directors, effective June 1, 2026. The appointment was disclosed via press release on June 3, 2026, and includes compensation details of an $85,320 annual cash retainer and an equity grant of $189,590.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-03
Item 5.02
Johnson Controls International plc appointed Irene Esteves as a new director to the Board on June 3, 2026, with assignment to the Audit Committee. The appointment includes compensatory arrangements consisting of an RSU award of $135,000 and a prorated retainer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
Item 5.02
The filing discloses the appointment of Scott R. Humphrey as Chief Financial Officer and Treasurer of Stoneridge, Inc., effective June 8, 2026. While the section also mentions Robert J. Hartman's departure from the Interim CFO role, the principal disclosed action centers on the appointment of a permanent CFO with detailed background, qualifications, and compensation terms. This is a material executive appointment affecting the company's principal financial officer position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
Item 5.02
Following the Arrangement closing, Joel Block was appointed as Chief Executive Officer, Kurt Kalbfleisch was appointed to the board, and Marcus Dent and Nicholas Gates were appointed as directors with committee assignments. These appointments represent a significant change in corporate governance and executive leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
Item 5.02
CMS Energy appointed Srikanth Maddipati as executive vice president and chief financial officer, effective June 3, 2026, succeeding retiring CFO Rejji P. Hayes. Maddipati brings 12 years of tenure at the company and assumes the role with a defined compensation package.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-03
Item 5.02
Rita Johnson-Greene, the Company's CFO, was appointed as principal accounting officer on June 3, 2026, following Ramesh Ramachandran's resignation as Chief Accounting Officer on May 29, 2026. While the filing discloses both a departure and an appointment, the principal disclosed action centers on the appointment of Johnson-Greene to the principal accounting officer role, a material executive position. The appointment of a CFO to assume principal accounting officer duties is material to investors assessing the company's financial reporting structure and controls.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
Item 5.02
The filing discloses the appointment of Matt McLaughlin as Chief Executive Officer effective May 28, 2026, along with detailed compensation arrangements including a $625,000 base salary, equity awards (options, RSUs, and PRSUs totaling over 1.1 million shares), and severance protections. While the section also covers Jon Carpenter's departure and Stuart Frankel's board appointment, the principal disclosed action centers on the CEO appointment, which is material to investors assessing leadership and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-03
Item 5.02
The filing discloses both a departure (Joseph Kimmell's retirement as EVP Operations effective June 26, 2026) and three executive appointments (Wade Lyall as Chief Sales Officer, John Kastanek as Chief Customer Experience Officer, and Andrew Houser as Senior Vice President of Manufacturing, all effective June 2, 2026). While both events are disclosed, the appointments of three officers to key operational roles represent the principal forward-looking action and structural change to the company's leadership. The departure is addressed through a consulting transition arrangement, making the appointments the more salient event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-03
Item 5.02
Luke A. Hewko was appointed as Chief Financial Officer of GEN Restaurant Group, Inc., effective June 1, 2026, succeeding retiring CFO Thomas V. Croal. The appointment includes a base salary of $300,000 and represents an orderly succession in the CFO role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
Item 5.02
The filing discloses the appointment of Darin Rovell as Chief Accounting Officer effective June 22, 2026, following Board approval on June 1, 2026. While the section also details compensatory arrangements (base salary of $350,000, bonus opportunity, RSU grant of 325,000 shares, and severance terms), the principal disclosed action is the appointment of an officer to a named executive position. The compensation details are ancillary to the appointment itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-03
Item 8.01
Major General Malcolm Frost's appointment to the Advisory Board is disclosed as a material personnel action. While an advisory board position is typically less material than an officer or director appointment, the specific focus on guiding technical development of the Company's core infrastructure for orbital economy and space/defense applications suggests this is a strategically significant appointment that would inform a reasonable investor's assessment of the Company's technical direction and capabilities.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
Item 5.02
The company appointed four directors (Dange, Dunham, Oakley, Tomba) to the board on May 28, 2026, appointed Timothy Ramdeen as Chairman and CEO, and appointed Sukhvinder Gill as Chief Financial Officer and COO in connection with the IPO.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-03
The filing discloses the appointment of James Sapirstein as Chief Executive Officer, announced via press release on June 3, 2026. This is a material executive appointment at the C-suite level that would affect a reasonable investor's assessment of the company's leadership and direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-03
The filing discloses multiple executive appointments on June 1, 2026, most notably Tyler Gates as President and Chief Executive Officer and Board Chair, William Keneally as Chief Financial Officer, and three new directors (Admiral Scott Swift as Board Chair, Major General Pete Fesler, and Brian Archer as Audit Committee Chair). While the filing also discloses three director resignations (Ian Charles, Alexander Ruckdaeschel, and Lyron Bentovim), the principal disclosed action centers on the appointment of new leadership, particularly the CEO transition from Bentovim to Gates. This represents a material change in executive leadership and board composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-03
The filing's primary disclosure under Item 5.02(d) is the appointment of Hon Nam Lee (Alvars) as an independent director on June 1, 2026, filling a newly created directorship and serving as Chair of the Nominating and Corporate Governance Committee. While Item 8.01 also discloses Timothy William Murphy's transition from independent director to General Counsel, the substantive new appointment of Lee is the central event. This is material as it affects board composition and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-03
The filing discloses the appointment of Rick Gonzalez as Chief Commercial Officer of Celularity Inc., effective May 29, 2026, reporting directly to the CEO. This is a material executive appointment that would affect investor assessment of the company's leadership and commercial strategy, particularly given the emphasis in the shareholder letter on commercial opportunities for cenplacel-L and the Lifebank platform.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-03
Item 5.02
NextDecade appointed John Zuklic as Chief Financial Officer, effective July 6, 2026. Zuklic brings 30+ years of energy industry experience, including prior roles at CITGO and Phillips 66.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-03
Item 5.02
The filing discloses the appointment of Dr. Anna Greka as a Class III director of Ovid Therapeutics, effective June 15, 2026, following Board approval on May 29, 2026. The principal disclosed action is a person taking a role (director and committee member), making this an executive appointment. Dr. Greka's appointment is material as it represents a change in board composition and governance structure, and her credentials as a Harvard Medical School professor with significant biotech experience would be relevant to investor assessment of the company's leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-03
Item 5.02
The disclosure centers on the appointment of Coree Thomas as Vice President and Chief Accounting Officer effective August 6, 2026, a principal accounting officer role. While the section also mentions Faez Kaabi's resignation, the substantive action disclosed is Thomas's appointment to a critical financial reporting position. The appointment of a principal accounting officer is material to investors assessing the company's financial reporting infrastructure and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
Daniel J. Ryan was elected to the Board of Directors of Zions Bancorporation on June 2, 2026, increasing the board from 11 to 12 members, and was also appointed to the Audit and Risk Oversight Committees effective July 1, 2026. This is a clear director appointment that would be material to investors assessing the composition and governance of the bank.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
Ms. Jillian Evanko was appointed as an Independent Director on Honeywell's Board of Directors and as a member of the Audit Committee, effective June 1, 2026. Evanko brings significant executive experience as the former CEO of Chart Industries.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
The filing discloses the Board's appointment of Julie Knecht as senior vice president and Chief Financial Officer effective August 1, 2026, succeeding retiring Rafael Lizardi after 25 years. While the disclosure includes both a departure (Lizardi's retirement) and an appointment (Knecht's promotion), the principal action centers on the appointment of a named executive to a material C-suite role. The appointment includes specified compensation ($700,000 base salary and $2 million in equity), making this a significant executive succession event material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
The filing discloses that Russ Montgomery will be promoted effective September 1, 2026, to Vice President, Accounting and Chief Accounting Officer of the general partners of PAA and PAGP. While the filing also mentions Chris Herbold's retirement on August 31, 2026, the principal announced action centers on Montgomery's appointment to a named executive officer position. The Chief Accounting Officer role is material to investors' assessment of financial reporting oversight and internal controls.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-02
Item 5.02
The disclosure centers on Russ Montgomery's promotion to Vice President, Accounting and Chief Accounting Officer effective September 1, 2026, a material executive appointment. While Chris Herbold's retirement is also mentioned, the principal action disclosed is Montgomery's appointment to the chief accounting officer role, a position responsible for financial reporting and accounting oversight. The appointment of a new CAO is material to investors assessing the registrant's financial reporting controls and leadership continuity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-02
Item 5.02
Richard Dirkson was appointed as Senior Vice President, Corporate Controller (principal accounting officer) effective May 28, 2026, with a base salary of $360,000, 50% target bonus, and 14,000 Class B Profit Units. The appointment also involved the departure of Tina Beskid as Chief Accounting Officer.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
Guy Wanger was appointed as Chief Accounting Officer and principal accounting officer of Salesforce, effective June 15, 2026. While the disclosure includes compensatory details (base salary of $700,000, 70% bonus target, $2 million sign-on bonus, and $9 million equity award), the principal disclosed action is the appointment of an officer to a key financial role. The appointment of a principal accounting officer is material to investors as it affects the registrant's financial reporting and internal controls oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
On June 1, 2026, Oncolytics Biotech appointed John McAdory as Chief Operating Officer and Stephen Glover as a director. These senior leadership appointments represent material changes to the company's governance and management structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
The filing discloses multiple executive appointments effective August 3, 2026: Ling Hai appointed as Chief Financial Officer (with detailed compensation including $850,000 base salary and $1,500,000 LTI award), Linda Kirkpatrick appointed as Chief Services Officer, and Craig Vosburg transitioning to Vice Chair. While the section also mentions Sachin Mehra's transition to Chief Business Officer and Timothy Murphy's retirement, the principal disclosed actions center on new appointments to key officer roles, particularly the CFO succession. These are material changes to the Company's executive leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
Paul McElhinney was appointed as Chief Executive Officer effective October 1, 2026, and as Chairman effective January 1, 2027. The appointment includes a comprehensive employment agreement with $1.1M base salary, $15M option grant, $5M RSU grant, and severance provisions. Russell Ford's concurrent retirement as CEO and Chairman is disclosed as context for the transition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Land Corporation, effective June 1, 2026, with assignment to three board committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Commercial Corporation, effective June 1, 2026, and assigned to three board committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Capital Corporation, effective June 1, 2026, and appointed to three Board committees: Compensation, Ethics/Nominating/Corporate Governance, and Valuation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
George "Chip" Stelljes, III was elected to the Board of Directors of Gladstone Investment Corporation, effective June 1, 2026, and assigned to three board committees: Compensation, Ethics/Nominating/Corporate Governance, and Valuation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
The filing discloses the appointment of two new directors, Jeff Farrow and Reid Waldman, M.D., to the Board of Directors effective May 29, 2026, along with their committee assignments. While the section also mentions compensatory arrangements (stock options and retainers), the principal disclosed action is the appointment of these individuals to board roles, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
Dave Caspers was appointed as President and Chief Executive Officer and Board member of Ardent Health, Inc. effective June 2, 2026, succeeding Martin J. Bonick. The appointment includes an employment agreement and equity grants.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 80%
filed 2026-06-02
Item 5.02
On June 1, 2026, Cue Biopharma appointed Sumita Ray as Chief Legal & Compliance Officer and Corporate Secretary, Michael Meluzio as Vice President and Principal Accounting Officer, and Daniel Camardo and Viola Meehan as directors. The appointments represent material governance and executive leadership changes, including board restructuring from seven to five directors and committee assignments for the new board members.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-02
Item 5.02
Todd Heeter was appointed as interim Chief Financial Officer effective May 28, 2026, under a consulting agreement providing $125,000 per month for six months. This appointment follows the departure of Kevin Beth as CFO on May 27, 2026, and Brian Meents as Chief Operating Officer, representing material changes to senior management.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-02
Item 5.02
Lawrence Y. Kim was appointed to the additional position of Chief Commercial Officer effective June 1, 2026. While the disclosure also includes compensatory arrangements (salary increase to $850,000, bonus opportunity of 125%, long-term equity awards of $2,000,000 annually, and a $3,000,000 performance retention grant), the principal disclosed action is the appointment to a new executive officer role. The appointment of an executive to a significant new position is material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
The disclosure centers on the appointment of Bryan Kennedy as a director of Southern First Bancshares, Inc. and Southern First Bank effective June 1, 2026, with assignment to the Risk Committee. While the section also mentions his participation in standard director compensation arrangements, the principal action disclosed is his appointment to the board, making this an exec_appointment event. The material nature is supported by Kennedy's extensive banking background, his role as Lead Independent Director of a NYSE-traded company, and the Boards' explicit statement that his experience will enhance the Company's governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-02
Item 8.01
The disclosure announces the appointment of Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology, a senior technical leadership role guiding development of the Company's core nanomagnetic AI chip technology for space and defense markets. This executive appointment is material to investors assessing the Company's technical capability and strategic direction in a key technology area.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-02
Item 5.02
The filing discloses the appointment of Daniel Clifford Rogers as a member of the Board and chair of the Audit Committee on June 2, 2026, replacing Dr. Risa Stack. While Dr. Stack's resignation is mentioned, the principal disclosed action centers on Mr. Rogers taking a role—specifically a board seat and audit committee chair position—making this an exec_appointment event. The appointment is material as it involves a change in board composition and audit committee leadership at an acquisition company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-02
Item 5.02
The filing discloses the appointment of Georgina Smith as Chief Accounting Officer effective June 1, 2026, with detailed background information on her qualifications and prior roles. While the section also mentions Bernard Skaggs's termination as CFO, the substantive disclosure centers on the appointment of a new accounting officer to a material position. The appointment of a CAO is material to investors assessing the company's financial reporting and internal control infrastructure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-02
Item 5.02
Jeffrey Brown was appointed to multiple senior officer positions on June 1, 2026, including Vice-President and Principal Financial Officer of the parent company and President and Chief Operating Officer of key subsidiaries. While the disclosure includes compensatory details (base salary of $275,000, 100,000 share grant, severance terms), the principal disclosed action is the appointment itself to these material executive roles. The appointment is material to investors as it affects the registrant's senior management structure and financial oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
Mr. Einav Eliraz was appointed Chief Financial Officer of VisionWave IL Ltd. (a wholly-owned subsidiary) effective June 1, 2026, with an employment agreement disclosing his salary, performance bonus eligibility, and a material equity grant of 500,000 options. The filing emphasizes his anticipated significant role in the Company's consolidated financial reporting, SEC compliance, M&A activities, and strategic initiatives across global operations, making this a material executive appointment despite the subsidiary structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-02
Item 5.02
Ana Garcia was appointed as Chief Financial Officer effective June 1, 2026, with a base salary of $300,000, up to 50% bonus, and a $300,000 RSU award. The appointment also included severance provisions and replaced Alvin McCoy III in the CFO role.
View raw filing on EDGAR →